Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives… Grant US-RE46907-E1 United States of America 26 Jun 2018
2—AMINO—N— [7—METHOXY—2, 3-DIHYDROIMIDAZO-[1, 2-C] QUINAZOLIN-5-YL] PYRIMIDINE—5—CARBOXAMID… Application WO-2017153220-A1 World Intellectual Property Organisation (WIPO) 14 Sep 2017
Alkoxy-substituted 2,3-dihydroimidazo[1,2-C]quinazolines Grant US-9730943-B2 United States of America 15 Aug 2017
USE OF SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINES Application WO-2016142313-A1 World Intellectual Property Organisation (WIPO) 15 Sep 2016
Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives… Grant US-9149526-B2 United States of America 06 Oct 2015
Small molecule antagonists of phosphatidylinositol-3,4,5-triphosphate (PIP3) and uses… Grant US-9040585-B2 United States of America 26 May 2015
USE OF SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINES FOR TREATING LYMPHOMAS Application WO-2014166820-A1 World Intellectual Property Organisation (WIPO) 16 Oct 2014
Small molecule antagonists of phosphatidylinositol-3,4,5-triphosphate (PIP3) and uses… Grant US-8628961-B2 United States of America 14 Jan 2014
PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS FOR THE TREATMENT OF CHILDHOOD CANCERS Application WO-2013067306-A1 World Intellectual Property Organisation (WIPO) 10 May 2013
USE OF SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINES Application WO-2012136549-A1 World Intellectual Property Organisation (WIPO) 11 Oct 2012
SIRNA inhibition of PI3K P85, P110, and AKT2 and methods of use Grant US-8198252-B2 United States of America 12 Jun 2012
AMINOALCOHOL SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINE DERIVATIVES USEFUL FOR… Application WO-2012062748-A1 World Intellectual Property Organisation (WIPO) 18 May 2012
ARYLAMINOALCOHOL-SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINOLINES Application WO-2012062743-A1 World Intellectual Property Organisation (WIPO) 18 May 2012
ALKOXY-SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINES Application WO-2012062745-A1 World Intellectual Property Organisation (WIPO) 18 May 2012
Use of substituted 2,3-dihydroimidazo[1,2-c]quinazolines for the treatment of myeloma Application EP-2168583-A1 European Patent Office 31 Mar 2010
Combinations of substituted 2,3-dihydroimidazo[1,2-c]quinazolines Application EP-2168582-A1 European Patent Office 31 Mar 2010
THE USE OF NELFINAVIR AS A RADIATION SENSITIZER Application WO-2006044808-A1 World Intellectual Property Organisation (WIPO) 27 Apr 2006